Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Safety and cost benefit of an accelerated infliximab infusion protocol in the treatment of ambulatory patients with inflammatory bowel diseases.

Authors
Type
Published Article
Journal
Expert Opinion on Biological Therapy
1744-7682
Publisher
Informa UK (Ashley Publications)
Publication Date
Volume
14
Issue
3
Pages
277–282
Identifiers
DOI: 10.1517/14712598.2014.866649
PMID: 24359522
Source
Medline
License
Unknown

Abstract

Accelerated 30-min infliximab infusions significantly reduced nursing time, cost and increased patient satisfaction without increasing infusion reactions. Increased patient freedom and improved efficiency in healthcare delivery can be expected.

Statistics

Seen <100 times